Revalidation
Introduced by the General Medical Council in the UK in December 2012, revalidation represents a major shift in the regulation of the medical profession. Our research into revalidation began in 2010 and has developed since then into a signficant and multi-faceted body of work.
A three stage programme of work funded by the Health Foundation between 2010 and 2016 looked at revalidation in policy, in practice and in public. Further work in this stream focuses on evaluating the impacts of revalidation since its implementation. Led by CAMERA Director Dr Julian Archer, the UK Medical Revalidation Evaluation coLLAboration (UMbRELLA) is a major evaluative research study into the regulatory impacts of medical revalidation, commissioned by the General Medical Council, and delivered independently by a UK-wide collaboration. More information about UMbRELLA can be found on its dedicated UMbRELLA website, Twitter (@revalidation), Facebook and LinkedIn. CAMERA is also a research partner in an evaluation of the impacts of revalidation, commissioned by the Department of Health in England through the Policy Research Programme. This study is led by Manchester Business School at the University of Manchester with researchers from CAMERA and from the Centre for Health Economics at the University of York.
Publications detailing findings from this research stream are available on our completed research page.